Two of the Center’s seven Accelerator portfolio companies recently received FDA approval for innovative medical technologies. Wadsworth Technologies announced in September, 2009 that their DermaLOC wound closure system had been approved by the FDA. Pluromed announced shortly thereafter that they had received FDA approval for BackStop, a device used in ureteroscopic kidney stone management procedures.
